# NICU Antibiotics and Outcomes Trial

> **NCT03997266** · PHASE4 · COMPLETED · sponsor: **Michael Morowitz** · enrollment: 359 (actual)

## Conditions studied

- Microbial Colonization
- Extreme Prematurity
- Early-Onset Neonatal Sepsis
- Late-Onset Neonatal Sepsis
- Necrotizing Enterocolitis of Newborn
- Death; Neonatal

## Interventions

- **DRUG:** Ampicillin
- **DRUG:** Gentamycin
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03997266
- **Lead sponsor:** Michael Morowitz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-05
- **Primary completion:** 2026-01-15
- **Final completion:** 2026-01-15
- **Target enrollment:** 359 (ACTUAL)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03997266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03997266, "NICU Antibiotics and Outcomes Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03997266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*